Perioperative strategy during the chronic use of antithrombotics;Perioperatief beleid bij gebruik van antitrombotica

Tijdschrift voor Geneeskunde

Volumn 65, Issue 22, 2009, Pages 1070-1080

  Vandermeulen, E ^a   Verhaeghe, R ^a   Verhamme, P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951926871     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/TVG.65.22.2000654     Document Type: Review

References (42)

1. DOUKETIS JD, BERGER PB, DUNN AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). American College of Chest Physicians. Chest 2008; 133 (6 Suppl): 299S-339S.
2. GAGE BF, WATERMAN AD, SHANNON W, BOECHLER M, RICH MW, RADFORD MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
3. VAN WALRAVEN C, HART RG, WELLS GA, et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003; 163: 936-943.
4. ANSELL JE. The perioperative management of warfarin therapy. Arch Intern Med 2003; 163: 881-883.
5. DUNN AS, TURPIE AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-908.
6. SPYROPOULOS AC, DOUKETIS JD. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation. Int Angiol 2008; 27: 333-343.
7. TORN M, ROSENDAAL FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003; 123: 676-682.
8. FUSTER V, RYDÉN LE, CANNOM DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
9. DENTALI F, CROWTHER MA. Management of excessive anticoagulant effect due to vitamin k antagonists. Hematology Am Soc Hematol Educ Program 2008; 266-270.
10. COLLET JP, MONTALESCOT G, BLANCHET B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-2367.
11. MERRITT JC, BHATT DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 2004; 17: 21-27.
12. CHASSOT PG, DELABAYS A, SPAHN DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-328.
13. FERRARI E, BENHAMOU M, CERBONI P, MARCEL B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-459.
14. BURGER W, CHEMNITIUS JM, KNEISSL GD, RÜCKER G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257: 399-414.
15. VICENZI MN, MEISLITZER T, HEITZINGER B, HALAJ M, FLEISHER LA, METZLER H. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96: 686-693.
16. RUPPEN W, DERRY S, MCQUAY HJ, MOORE RA. Incidence of epidural haematoma and neurological injury in cardiovascular patients with epidural analgesia/anaesthesia: systematic review and meta-analysis. BMC Anesthesiol 2006; 6: 10.
17. VANDERMEULEN EP, VAN AKEN H, VERMYLEN J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg; 79: 1165-1177.
18. LEE LA, POSNER KL, DOMINO KB, CAPLAN RA, CHENEY FW. Injuries associated with regional anesthesia in the 1980s and 1990s: a closed claims analysis. Anesthesiology 2004; 101: 143-152.
19. VANDERMEULEN E. Is anticoagulation and central neural blockade a safe combination? Curr Opin Anaesthesiol 1999; 12: 539-543.
20. TRYBA M. Epidural regional anesthesia and low molecular heparin: Pro. Anästhesiol Intensivmed Notfallmed Schmerzther 1993; 28: 179-181.
21. SCHROEDER DR. Statistics: detecting a rare adverse drug reaction using spontaneous reports. Reg Anesth Pain Med 1998; 23 (6 Suppl 2): 183-189.
22. MOEN V, DAHLGREN N, IRESTEDT L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004; 101: 950-959.
23. Belgian Society for Anesthesia and Resuscitation. Belgian guidelines concerning drug induced alteration of coagulation and central neuraxial anesthesia. Acta Anaesthesiol Belg 2000; 51: 101-104.
24. VANDERMEULEN E, SINGELYN F, VERCAUTEREN M, BRICHANT JF, ICKX BE, GAUTIER P. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. Belgian Association for Regional Anesthesia Working Party on anticoagulants and central nerve blocks. Acta Anaesthesiol Belg 2005; 56: 139-146.
25. ROSENCHER N, BONNET MP, SESSLER DI. Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies. Anaesthesia 2007; 62: 1154-1160.
26. WARKENTIN TE, GREINACHER A, KOSTER A, LINCOFF AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). American College of Chest Physicians. Chest 2008; 133 (6 Suppl): 340S-380S.
27. SINGELYN FJ, VERHEYEN CC, PIOVELLA F, VAN AKEN HK, ROSENCHER N. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study. EXPERS Study Investigators. Anesth Analg 2007; 105: 1540-1547.
28. ERIKSSON BI, BORRIS LC, FRIEDMAN RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. RECORD1 Study Group. N Engl J Med 2008; 358: 2765-2775.
29. STANGIER J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 2008; 47: 285-295.
30. ERIKSSON BI, DAHL OE, ROSENCHER N, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007; 5: 2178-2185.
31. WIVIOTT SD, BRAUNWALD E, McCABE CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. TRITON-TIMI 3 Investigators. N Engl J Med 2007; 357: 2001-2015.
32. TANTRY US, BLIDEN KP, GURBEL PA. Prasugrel. Expert Opin Investig Drugs 2006; 15: 1627-1633.
33. FARID NA, SMITH RL, GILLESPIE TA, et al. The disposition of prasugrel, a novel thienopyridine, in humans. Drug Metab Dispos 2007; 35: 1096-1104.
34. DASGUPTA H, BLANKENSHIP JC, WOOD GC, FREY CM, DEMKO SL, MENAPACE FJ. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis. Am Heart J 2000; 140: 206-211.
35. HUANG F, HONG E. Platelet glycoprotein IIb/IIIa inhibition and its clinical use. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 187-196.
36. ROSOVE MH. Platelet glycoprotein IIb/IIIa inhibitors. Best Pract Res Clin Haematol 2004; 17: 65-76.
37. STEINHUBL SR. Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists. Coron Artery Dis 2003; 14: 381-386.
38. WHEELER GL, BRADEN GA, STEINHUBL SR, et al. The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy. Am Heart J 2002; 143: 602-611.
39. WANG SM, CALDWELL-ANDREWS AA, KAIN ZN. The use of complementary and alternative medicines by surgical patients: a follow-up survey study. Anesth Analg 2003; 97: 1010-1015.
40. FUGH-BERMAN A. Herb-drug interactions. Lancet 2000; 355: 134-138.
41. FARAH MH, EDWARDS R, LINDQUIST M, LEON C, SHAW D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000; 9: 105-112.
42. ROSE KD, CROISSANT PD, PARLIAMENT CF, LEVIN MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990; 26: 880-882.